Voluntary halt to all dosing in TROPOS trial of Cibotercept (KER-012) for pulmonary arterial hypertension by Keros Therapeutics.
FDA approves Omvoh (mirikizumab) for Crohn's disease, expanding its use to another major type of IBD by Eli Lilly.
CE Mark approval in EU/UK for BrainSense adaptive deep brain stimulation for Parkinson's by Medtronic.